Abstract: Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are a pillar of kidney disease therapy, but their efficacy remains unknown in autosomal dominant …
Abstract: Background: The primary aim of this study was to compare kidney end points between patients with type 2 diabetes (T2D) 36 months after initiation on a sodium-glucose …